Workers’ comp professionals are seeing delayed recovery as an increased challenge in claims – as injured employees may not be progressing along a medically reasonable and expected time frame. However, it can be difficult to pinpoint exactly why the delay is occurring in order to address the issue. We may believe the injured employee is simply not complying with treatment and malingering.
In June 2018, the Federal Drug Administration (FDA) approved Epidiolex, the first plant-derived cannabinoid medicine in the United States. With several states already moving toward legalization of medical marijuana, this is a major step for the federal government.
Management of opioid therapy can be influenced by the types of drugs filled, differing patient populations, and the nature of the injury. Don’t miss our latest video blog where we will review some of the differences that point to the importance of early intervention and identification of long term risk.
The Illinois Alternatives to Opioids Act of 2018 recently went into effect. Learn what this means for workers' compensation patients.
By Brian Allen, VP of Government Affairs
The Vermont Department of Labor has proposed a rule that would, by reference, incorporate the Department of Health opioid prescribing guidelines fo
Utilization and costs associated with compound medications fell significantly for both managed and unmanaged claims in 2017.